This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

JenaValve pushed for Edwards to divest JC Medical, US FTC tells court

By Wesley Brown ( November 18, 2025, 23:56 GMT | Insight) -- JenaValve pushed for Edwards Lifesciences to divest JC Medical, but was shut down, the US Federal Trade Commission told the US District Court for the District of Columbia during the first day of trial Tuesday over Edwards' attempt to acquire JenaValve. JenaValve Chief Executive John Kilcoyne was the first witness to take the stand, responding to questions from counsel for the FTC. A majority of the questioning centered around the Edwards acquisition of JC Medical, which closed in July 2024, just two days before the deal with JenaValve was announced.JenaValve pushed for Edwards Lifesciences to divest JC Medical, but was shut down as Edwards also moved to acquire JenaValve, the US Federal Trade Commission told the US District Court for the District of Columbia during the first day of trial Tuesday....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login